docetaxel anhydrous has been researched along with ferric ferrocyanide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (ferric ferrocyanide) | Trials (ferric ferrocyanide) | Recent Studies (post-2010) (ferric ferrocyanide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 910 | 1 | 609 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, Q; Li, L; Liu, S; Liu, W; Ran, H; Shang, T; Tan, M; Wang, Z; Xie, Z; Zhang, L; Zhang, W | 1 |
1 other study(ies) available for docetaxel anhydrous and ferric ferrocyanide
| Article | Year |
|---|---|
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Cell Survival; Docetaxel; Ferrocyanides; Humans; Imiquimod; Immunotherapy; Infrared Rays; Macrophages; Mice; Mice, Nude; Nanoparticles; Neoplasms; Optical Imaging; Photothermal Therapy; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |